What one share of Protara Therapeutics holds
We were founded on the principle of applying modern scientific, regulatory or manufacturing advancements to established mechanisms in
Protara Therapeutics’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Profit | −$1.36 |
|---|---|
| Capex (buildings and equipment) | $0.01 |
| Free cash flow | −$1.29 |
| Cash and investments | $2.74 |
| Book value | $2.73 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2014 | $38.48 | −$126.55 | $0.67 | −$131.06 | — | — |
| 2015 | — | −$51.94 | $0.48 | −$43.16 | — | $153.70 |
| 2016 | — | −$68.90 | $0.65 | −$57.86 | — | $92.61 |
| 2017 | — | −$85.01 | $0.08 | −$51.84 | — | $78.62 |
| 2018 | — | −$45.80 | $0.26 | −$51.60 | — | $9.93 |
| 2019 | — | −$3.04 | $0.18 | −$2.13 | — | −$0.81 |
| 2020 | — | −$4.70 | $0.12 | −$3.36 | — | $17.77 |
| 2021 | — | −$4.21 | $0.05 | −$3.12 | — | $14.41 |
| 2022 | — | −$5.86 | $0.01 | −$2.36 | — | $9.06 |
| 2023 | — | −$3.57 | $0.00 | −$3.32 | — | $6.01 |
| 2024 | — | −$2.17 | $0.00 | −$1.74 | — | $4.77 |
| 2025 | — | −$1.34 | $0.00 | −$1.32 | — | $3.67 |
Common questions about Protara Therapeutics
How much does one share of Protara Therapeutics earn?
Over the last 12 months, Protara Therapeutics lost $1.36 for each share.
Does Protara Therapeutics pay a dividend?
Protara Therapeutics didn’t pay a dividend over the last 12 months, according to its SEC filings.
What is Protara Therapeutics’s book value per share?
Protara Therapeutics’s book value is $2.73 per share: what would be left for each share if it sold everything at the values on its books and paid every debt, as of June 30, 2026.
How much cash and debt does each share of Protara Therapeutics have?
Each share of Protara Therapeutics has $2.74 of cash and investments, as of June 30, 2026.
What is Protara Therapeutics’s free cash flow per share?
−$1.29 per share over the last 12 months. Free cash flow is the cash left over after spending on buildings and equipment.
Has Protara Therapeutics bought back shares?
Protara Therapeutics’s share count rose about 55813% from 2014 to 2025. That dilution means each share owns a smaller slice of the company.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.